4//SEC Filing
QUAY STEVEN C 4
Accession 0000950170-25-076523
CIK 0001488039other
Filed
May 21, 8:00 PM ET
Accepted
May 22, 6:27 PM ET
Size
6.1 KB
Accession
0000950170-25-076523
Insider Transaction Report
Form 4
QUAY STEVEN C
DirectorCEO10% Owner
Transactions
- Purchase
Common Stock
2025-05-21$0.88/sh+11,239$9,887→ 13,898 total
Holdings
- 22,254(indirect: By LLC)
Common Stock
Footnotes (2)
- [F1]The price reported represents the weighted average purchase price per share. The shares were purchased in multiple transactions at prices ranging from $0.8794 to $0.9100. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of share purchased at each separate price.
- [F2]Ensisheim Partners, LLC ("Ensisheim") is wholly owned by the Reporting Person and Dr. Shu-Chih Chen. The Reporting Person and Dr. Chen share voting and investment power over the securities held by Ensisheim. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
Documents
Issuer
ATOSSA THERAPEUTICS, INC.
CIK 0001488039
Entity typeother
Related Parties
1- filerCIK 0001008227
Filing Metadata
- Form type
- 4
- Filed
- May 21, 8:00 PM ET
- Accepted
- May 22, 6:27 PM ET
- Size
- 6.1 KB